Related Experiment Video

Updated: Dec 8, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

596

The Age Distribution among Children Seeking Medical Treatment for Precocious Puberty in Taiwan

Pen-Hua Su1,2, Jing-Yang Huang3,4, Cho-Shun Li5

  • 1School of Medicine, Chung Shan Medical University, Taichung 41354, Taiwan.

International Journal of Environmental Research and Public Health
|September 22, 2020
PubMed

Insights

The number of children diagnosed with precocious puberty (PP) significantly increased between 2000 and 2013. This trend highlights the need for increased awareness of environmental factors and early medical intervention for PP.

Area of Science:

  • Pediatric Endocrinology
  • Public Health
  • Epidemiology

Background:

  • Precocious puberty (PP) presents significant physiological and psychological challenges for affected children.
  • Understanding trends in seeking medical care for PP is crucial for resource allocation and patient management.

Purpose of the Study:

  • To investigate the trends in prevalence and incidence of precocious puberty (PP) in children.
  • To analyze the changes in seeking medical care for PP over time.

Main Methods:

  • Utilized the Taiwan National Health Insurance Research Dataset (NHIRD) from 2000-2013.
  • Estimated prevalence and incidence of PP (ICD-9 code: 259.1) in boys (0-11 years) and girls (0-10 years).
  • Employed join-point regression to determine trends and compared management proportions within one year of diagnosis between different periods.

Main Results:

  • Prevalence of PP significantly increased from 2000 to 2013 for both boys and girls.
  • Incidence rates also showed a marked rise, with girls consistently having higher rates than boys.
  • The frequency of pediatric endocrinology outpatient visits for PP increased substantially across both genders during the study period.

Conclusions:

  • The study observed a significant increase in the frequency of medical visits for precocious puberty (PP) in both genders from 2000 to 2013.
  • Emphasizes the importance of monitoring children's health, environmental exposures (hormones, diet), and enhancing parental education regarding PP.
  • Recommends further research into PP surveillance and improved educational strategies to optimize medical resource utilization and timely care.
Abstract

Keywords:
childrenprecocious pubertyprevalence and incidenceseeking medical care

More Related Videos

Physical Activity Measurement in Children Accepting Table Tennis Training06:51

Physical Activity Measurement in Children Accepting Table Tennis Training

Published on: July 27, 2022

2.2K
Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation05:42

Z-Scores for Assessing Ovarian Reserve in Young Patients Undergoing Fertility Preservation

Published on: October 25, 2024

1.5K

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
166
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
135